Justin M. Barnes
@Barnes_J_M
Husband, father, & incoming radiation oncologist @MayoClinic via @WashUMedRadOnc. Working to improve access to cancer care. Tweets=mine
Accrual completed! ✅ Looking forward to sharing our experiences & results! Thanks to all the patients who are participating! And thanks to @ConquerCancerFd & @SitemanCenter for the support! @WashUMedRadOnc
🔥Thrilled to share a major residency goal (& labor of♥️ for 2 yrs) was reached today: ✅trial opened We're helping patients with #cancer complete #radiotherapy and avoid delays via addressing unmet needs w/ additional assistance 📣to amazing mentors #JoannaYang & @fumikochino!
Graduated residency last week! So grateful for the training & opportunities I’ve had and the MANY people supporting me along the way, from spouse/family to coresidents to faculty (especially PD/mentor/sponsor Joanna Yang). Excited for my next step as junior faculty @MayoRadOnc!
"Overall survival & quality of life superiority in modern phase Ill oncology trials." Phase Ill onc RCTs are commonly called "positive." But this is usually based on alternative endpoint improvement. Gains in either OS or QOL are uncommon, & exceedingly rare in combo. #ASCO25
Just 2 incoming @MayoRadOnc faculty enjoying the views & company at the @JAMAOnc reception. #ASCO25
Broad-based genomic testing (beyond focused biomarker testing alone) for patients with advanced NSCLC led to ⬆️ targeted agent use and subsequently ⬆️ PFS & OS. @TrishaSantosMD #ASCO25
Adverse financial events prior to a cancer diagnosis lead to worse survival. Neat analysis of a linkage of cancer database with consumer data! #ASCO25 @DrRobinYabroff
🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. SRS Standard of Care for 5-20 brain mets 🚨🚨🚨
The MN delegation for @ASTRO_org Advocacy Day joined with diverse rad oncs from multiple states to champion NIH/NCI funding, prior auth reform, and support for ROCR. Hopeful and optimistic that we can preserve cancer research and #radonc for future generations. #ASTROAdvocacy
New exec order directs the Trump admin to set target drug prices in the U.S. W/o “significant” manufacturer progress toward the targets in 30 days, the admin will begin implementing a most-favored-nation (MFN) model. #ASCOAdvocacy Our statement: brnw.ch/21wSB29
@WashUMedRadOnc adaptive APRT @RobAPRT presenting in the #ESTRO25 plenary hall his award winning work on demonstrating the financial savings of implementing an adaptive APRT in a busy ART clinic ☢️
The prolific @JoshuaSchiffMD deconstructs dogma at the Sim-free RT session at @ESTRO_RT This is surely the future, esp for low-risk palliative treatment, esp as on-set imaging improves Global Onc implications too importantly! @KeckMedicineUSC @uscnorris @WashUMedRadOnc
@WashUMedRadOnc PGY-5/phys scientist @LeMoyneHabimana presenting an elegant 🐭 model for assessing the impact of focal radiation on a specific part of the GI tract to further our understanding of radiation induced GI injury #ESTRO25
10 years fast forward data confirms similar IBTR and cosmesis and similar to 5 years #estro2025 @ErinGillespieMD
Danish data with longer follow up shows no difference in lymphedema or LRR with RNI hypofractionation @Icro_Meattini @ErinGillespieMD @DocGlaser @AndrewKellerMD #estro2025